Column Group LLC — 13F Holdings & Portfolio

CIK 1833486 · latest 13F-HR filed 2026-08-14

Column Group LLC manages $88.1M in 13F-reported U.S. long-equity assets across 3 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are SRZNW (56.46%), ORIC (43.53%), RVMD (0.01%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 0 new positions, exited 0, added to 1, and trimmed 2.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Filer Information
Address
1 LETTERMAN DRIVE, BUILDING D
SUITE M-900
SAN FRANCISCO, CA 94129
Phone
(415) 865-2050
Filing Manager
Column Group LLC
San Francisco, CA
Signatory
James Evangelista
Chief Financial Officer
Loading holdings…
AUM

$88.1M

Long-equity book

Holdings

3

Distinct positions

Period

2026-06-30

Filed 2026-08-14

Q/Q Activity

+0 / −0 / ↑1 / ↓2

vs 2026-03-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • Revolution Medicines Inc$4.1K +92.6%
Show all 1

Top Trims

  • ORIC Pharmaceuticals Inc.-$6.5M -14.5%
  • Surrozen, Inc.-$6.1M -10.9%
Show all 2

New Positions

  • No new positions this quarter.
Show all 0

Exited Positions

  • No exits this quarter.
Show all 0
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 Surrozen, Inc. SRZNW 86889P109 $49.7M 56.46% 1,916,950 SH
2 ORIC Pharmaceuticals Inc. ORIC 68622P109 $38.3M 43.53% 3,540,777 SH
3 Revolution Medicines Inc RVMD 76155X100 $8.6K 0.01% 46 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $88.1M 3 0001193125-26-352333
2026-03-31 2026-05-18 $100.7M 3 0001193125-26-227853
2025-12-31 2026-02-13 $82.8M 5 0001193125-26-051393
2025-09-30 2025-11-14 $81.0M 5 0001193125-25-282923